Patients with high HOXA11-AS expression presented more lymphovascular invasion, lymph node metastasis, and recurrence relative to patients with low HOXA11-AS expression, but this relationship was not statistically significant. Here, HOXA11 is linked to metastatic malignant neoplasm in the lymph nodes.